Drug Control Act; classifies gabapentin as a Schedule V controlled substance. (HB2557)
Introduced By
Sen. Todd E. Pillion (R-Abingdon) with support from co-patron Del. Israel O'Quinn (R-Bristol)
Progress
✓ |
Introduced |
✓ |
Passed Committee |
✓ |
Passed House |
✓ |
Passed Senate |
✓ |
Signed by Governor |
☐ |
Became Law |
Description
Drug Control Act; Schedule V; gabapentin. Classifies gabapentin as a Schedule V controlled substance. Current law lists gabapentin as a drug of concern. The bill also removes the list of drugs of concern from the Code of Virginia and provides that any wholesale drug distributor licensed and regulated by the Board of Pharmacy and registered with and regulated by the U.S. Drug Enforcement Administration shall have until July 1, 2020, or within six months of final approval of compliance from the Board of Pharmacy and the U.S. Drug Enforcement Administration, whichever is earlier, to comply with storage requirements for Schedule V controlled substances containing gabapentin. Read the Bill »
Outcome
History
Date | Action |
---|---|
01/09/2019 | Committee |
01/09/2019 | Prefiled and ordered printed; offered 01/09/19 19101661D |
01/09/2019 | Referred to Committee on Health, Welfare and Institutions |
01/21/2019 | Impact statement from DPB (HB2557) |
01/22/2019 | Reported from Health, Welfare and Institutions (22-Y 0-N) (see vote tally) |
01/24/2019 | Read first time |
01/25/2019 | Read second time and engrossed |
01/28/2019 | Read third time and passed House BLOCK VOTE (99-Y 0-N) |
01/28/2019 | VOTE: BLOCK VOTE PASSAGE (99-Y 0-N) (see vote tally) |
01/29/2019 | Constitutional reading dispensed |
01/29/2019 | Referred to Committee on Education and Health |
02/07/2019 | Reported from Education and Health with substitute (15-Y 0-N) (see vote tally) |
02/07/2019 | Committee substitute printed 19106567D-S1 |
02/08/2019 | Impact statement from DPB (HB2557S1) |
02/08/2019 | Constitutional reading dispensed (40-Y 0-N) (see vote tally) |
02/11/2019 | Read third time |
02/11/2019 | Reading of substitute waived |
02/11/2019 | Committee substitute agreed to 19106567D-S1 |
02/11/2019 | Engrossed by Senate - committee substitute HB2557S1 |
02/11/2019 | Passed Senate with substitute (40-Y 0-N) (see vote tally) |
02/13/2019 | Placed on Calendar |
02/13/2019 | Senate substitute agreed to by House 19106567D-S1 (97-Y 0-N) |
02/13/2019 | VOTE: ADOPTION (97-Y 0-N) (see vote tally) |
02/15/2019 | Enrolled |
02/15/2019 | Bill text as passed House and Senate (HB2557ER) |
02/15/2019 | Impact statement from DPB (HB2557ER) |
02/15/2019 | Signed by Speaker |
02/15/2019 | Signed by President |
02/19/2019 | G Governor's Action Deadline Midnight, March 25, 2019 |
02/19/2019 | Enrolled Bill communicated to Governor on February 19, 2019 |
02/19/2019 | G Governor's Action Deadline Midnight, March 26, 2019 |
03/05/2019 | G Approved by Governor-Chapter 214 (effective 7/1/19) |
03/05/2019 | G Acts of Assembly Chapter text (CHAP0214) |